Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Ipsen Doubles Down On FOP With Blueprint Pact
Deal could be worth up to $535m
Oct 16 2019
•
By
Kevin Grogan
Ipsen has two shots at FOP after deal with Blueprint of the US • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip